SPD602

DRUG3 trials

Sponsors

Shire

Conditions

Beta-ThalassemiaBeta-thalassemiaIron ChelationIron Metabolism DisordersIron OverloadIron Overload Due to Repeated Red Blood Cell TransfusionsMetabolic DiseasesTransfusional Hemosiderosis

Phase 2

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

TerminatedNCT01363908

ShireBeta-Thalassemia, Transfusional Iron Overload

Start: 2011-08-10End: 2014-05-13Updated: 2021-06-14

Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy

TerminatedNCT01604941

ShireIron Overload Due to Repeated Red Blood Cell Transfusions

Start: 2012-09-14End: 2014-04-18Updated: 2021-06-29

Treatment of Iron Overload Requiring Chelation Therapy

WithdrawnNCT01927913

ShireBeta-thalassemia, Iron Chelation, Iron Metabolism Disorders +4

Start: 2014-11-20End: 2015-10-30Updated: 2021-06-02